Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Odontogenic Cysts 1Nose Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1Liver Neoplasms 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

enzalutamide 2radium Ra 223 dichloride 1poly ICLC 1olaparib 1fluciclovine F-18 1cabazitaxel 1bempegaldesleukin 1afuresertib 1Radiosurgery 1Radionuclide Imaging 1Prednisone 1Nivolumab 1Docetaxel 1Clinical Trials, Phase I as Topic 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Castration-resistant Prostate Cancer × Radionuclide Imaging × Clear all
NCT04000776 2023-08-28

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Université de Sherbrooke

Completed
100 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡